Invesco
KURA icon

Invesco’s Kura Oncology KURA Stock Holding History

Invesco’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Sell
198,236
-8,535
-4% -$80.5K ﹤0.01% 2546
2026
Q1 		$1.68M Sell
206,771
-2,599
-1% -$22.3K ﹤0.01% 2620
2025
Q4 		$2.18M Buy
209,370
+26,683
+15% +$280K ﹤0.01% 2580
2025
Q3 		$1.62M Buy
182,687
+41,956
+30% +$299K ﹤0.01% 2712
2025
Q2 		$812K Buy
140,731
+43,515
+45% +$267K ﹤0.01% 2937
2025
Q1 		$642K Buy
97,216
+29,978
+45% +$234K ﹤0.01% 3052
2024
Q4 		$586K Buy
67,238
+799
+1% +$11.5K ﹤0.01% 3175
2024
Q3 		$1.3M Sell
66,439
-162,760
-71% -$3.3M ﹤0.01% 2804
2024
Q2 		$4.72M Sell
229,199
-84,873
-27% -$1.74M ﹤0.01% 2223
2024
Q1 		$6.7M Buy
314,072
+244,945
+354% +$4.76M ﹤0.01% 2048
2023
Q4 		$994K Buy
69,127
+10,232
+17% +$101K ﹤0.01% 2897
2023
Q3 		$537K Buy
58,895
+911
+2% +$9.25K ﹤0.01% 3164
2023
Q2 		$613K Sell
57,984
-2,117
-4% -$25K ﹤0.01% 3134
2023
Q1 		$735K Sell
60,101
-9,171
-13% -$114K ﹤0.01% 3060
2022
Q4 		$860K Sell
69,272
-39
-0.1% -$567 ﹤0.01% 3004
2022
Q3 		$947K Sell
69,311
-2,594
-4% -$40K ﹤0.01% 2952
2022
Q2 		$1.32M Buy
71,905
+9,308
+15% +$134K ﹤0.01% 2885
2022
Q1 		$1.01M Sell
62,597
-1,738,030
-97% -$25.1M ﹤0.01% 3067
2021
Q4 		$25.2M Sell
1,800,627
-1,199,513
-40% -$19.4M 0.01% 1404
2021
Q3 		$56.2M Buy
3,000,140
+1,475,350
+97% +$27.8M 0.01% 1013
2021
Q2 		$31.8M Sell
1,524,790
-170,422
-10% -$4.23M 0.01% 1322
2021
Q1 		$47.9M Buy
1,695,212
+1,412,295
+499% +$44.7M 0.01% 1079
2020
Q4 		$9.24M Sell
282,917
-28,687
-9% -$1.01M ﹤0.01% 1851
2020
Q3 		$9.55M Buy
+311,604
New +$6.88M ﹤0.01% 1681
2018
Q3 		– Sell
-174,074
Closed -$3.17M – 3904
2018
Q2 		$3.17M Buy
174,074
+95,844
+123% +$1.62M ﹤0.01% 2445
2018
Q1 		$1.47M Buy
+78,230
New +$1.52M ﹤0.01% 2806

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Invesco's KURA Position: Q2 2026 in Review

Invesco reduced its Kura Oncology (KURA) stake by 4.1% in Q2 2026, selling an estimated $80.5K and leaving 198,236 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2546.

Invesco first reported a position in KURA in Q1 2018 and has held it in 26 quarters since. The position peaked at $56.2M in Q3 2021. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Invesco held 198,236 shares of Kura Oncology worth $2.17M as of Q2 2026.
  • Invesco sold 8,535 Kura Oncology shares in Q2 2026, an estimated $80.5K.
  • Kura Oncology made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2546 holding.
  • Invesco first reported a position in Kura Oncology in Q1 2018 and has held it in 26 quarters since.
  • Invesco's Kura Oncology position peaked at $56.2M in Q3 2021.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.